| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/2006 | EP1267904A4 Polypeptoid pulmonary surfactants |
| 02/08/2006 | EP1156822B1 Iin vitro method for synchronisation of oocyte maturation |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1068297B1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 02/08/2006 | EP1039933B1 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS |
| 02/08/2006 | EP1032669B1 Recombinant allergen with reduced enzymatic activity |
| 02/08/2006 | EP1007657B1 Hiv-specific oligonucleotides and methods of their use |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0948343B1 Alkyl peptide amides adapted for topical administration |
| 02/08/2006 | EP0831869B1 Diphosphonate derivatives of therapeutic agents |
| 02/08/2006 | EP0736041B1 Transparent liquid for encapsulated drug delivery |
| 02/08/2006 | EP0694067B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 02/08/2006 | EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 02/08/2006 | CN1732259A Method of degrading hardly degradable protein |
| 02/08/2006 | CN1732185A Method for the crystallization of human serum albumin |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1732023A Compositions and methods of using collajolie |
| 02/08/2006 | CN1732016A Modified cytokines for use in cancer therapy |
| 02/08/2006 | CN1732015A Low dose methods for treating disorders in which TNF-alpha activity is detrimental |
| 02/08/2006 | CN1732014A Templated native silk smectic gels |
| 02/08/2006 | CN1732013A Desamino-8-a-arginyl vasopressin analogs |
| 02/08/2006 | CN1732012A Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 02/08/2006 | CN1732001A Compositions for the treatment of macular degeneration |
| 02/08/2006 | CN1731997A Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 02/08/2006 | CN1731990A Nutritional composition for oral use |
| 02/08/2006 | CN1731988A Sustained release pharmaceutical composition |
| 02/08/2006 | CN1731982A Method of treating insulin resistance, adult onset diabetes and metabolic syndrome X |
| 02/08/2006 | CN1731934A Ace inhibitory peptides from plant materials |
| 02/08/2006 | CN1731932A Methods of diagnosis and treatment of interstitial lung disease |
| 02/08/2006 | CN1730494A Cobratide modified by polyethylene glycol, its preparation method and uses |
| 02/08/2006 | CN1730491A Cat omega interferon and its coding gene and uses |
| 02/08/2006 | CN1730488A Peptides for promoting platelet growth, accumulation and suppressing hypertension and its uses |
| 02/08/2006 | CN1730098A Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof |
| 02/08/2006 | CN1730097A Pharmaceutical composition for preventing and curing endometritis and retained afterbirth disease of milk cow |
| 02/08/2006 | CN1730096A Novel purpose of L-alanyl-L-glutamine dipeptide |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240834C LY6H gene |
| 02/08/2006 | CN1240718C Aggregates of human insulin derivatives |
| 02/08/2006 | CN1240717C Low-toxicity human interferon-alpha analog |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/08/2006 | CN1240713C New compound |
| 02/08/2006 | CN1240711C Novel peptide having angiotensin convertase inhibitory effect |
| 02/08/2006 | CN1240439C Genetic switch medicine for treating tumor |
| 02/08/2006 | CN1240436C Synergistic action of ossification growth peptide and granule cell colony stimulating factor in hematopoiesis |
| 02/08/2006 | CN1240392C Agent for promoting cell activation for external use |
| 02/07/2006 | US6995257 Notch3 gene and the corresponding protein, which are involved in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy); probes and primers; mutations in gene that indicate risk of developing CADASIL |
| 02/07/2006 | US6995252 A polynucleotide encoding a perinuclear thecaprotein (PT 32) which binds to tyrosine kinase c-Yes to induce oocyte activation; enhancing fertility, treating or diagnosing diminished fertility and/or abnormal spermiogenesis; contraception; screeing |
| 02/07/2006 | US6995249 Nucleic acid capable of binding specifically to Ras target protein |
| 02/07/2006 | US6995245 Formation of novel erythropoietin conjugates using transglutaminase |
| 02/07/2006 | US6995244 A mutant binding to prolactin receptor through site 1, does not bind through site 2 nor has diminished binding through site 2, and exhibits <1% of unmodified agonist activity; anticarcinogenic, -tumor and metastatis agents; breast/prostate cancer |
| 02/07/2006 | US6995242 Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof |
| 02/07/2006 | US6995240 Treatment of inflammatory disease |
| 02/07/2006 | US6995238 Cyclopeptide derivatives |
| 02/07/2006 | US6995188 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 02/07/2006 | US6995177 HCV NS3 protease inhibitors |
| 02/07/2006 | US6995175 Anticancer agents |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995147 Method of delaying the onset of diabetes |
| 02/07/2006 | US6995146 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/07/2006 | US6995141 Interleukin 1β protease and interleukin 1β protease inhibitors |
| 02/07/2006 | US6995140 Peptides and polypeptides useful for regenerating the nervous system |
| 02/07/2006 | US6995139 Cyclic undecapeptide pro-drugs and uses thereof |
| 02/07/2006 | US6995138 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/07/2006 | US6995137 Water-soluble natural film and its preparing method |
| 02/07/2006 | US6995136 Peptide fragments of murine epidermal growth factor as laminin receptor targets |
| 02/07/2006 | US6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 02/07/2006 | US6995134 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994990 Active modified hedgehog proteins |
| 02/07/2006 | US6994987 Process for producing tripeptides |
| 02/07/2006 | US6994981 Modulators of paraptosis and related methods |
| 02/07/2006 | US6994979 Drug screening for compounds that modulate the function of anti-apoptotic protein Bcl-2 to induce apoptosis; identifying antitumor agents |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994976 Monoclonal antibody that binds to TR3 (also known as Apo-3, DR3, LARD, Tramp, and WSL-1), a tumor necrosis factor receptor (TNFR) superfamily member of cell-surface antigens, and inhibits the proliferation of activated lymphocytes expressing TR3 |
| 02/07/2006 | US6994974 Drug screening for a substance that inhibits endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide from binding to amyloid-beta peptide; neurodegenerative disorders |
| 02/07/2006 | US6994970 Peptides which bind auto-antibodies for use in extracorporeal treatment; peptides bound to solid support for chromatography; specified amino acid sequence |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994862 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery |
| 02/07/2006 | US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 02/07/2006 | US6994859 Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994856 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | US6994847 Stabilized interferon compositions |
| 02/07/2006 | US6994842 Aerogel powder therapeutic agents |
| 02/07/2006 | CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/02/2006 | WO2006012644A2 Use of il-28 and il-29 to treat cancer |
| 02/02/2006 | WO2006012627A2 Actrii receptor polypeptides, methods and compositions |
| 02/02/2006 | WO2006012586A2 Modulation of fiaf and the gastrointestinal microbiota |
| 02/02/2006 | WO2006012541A2 Compositions and methods for treating excessive bleeding |
| 02/02/2006 | WO2006012539A1 Contraceptives based on sp22 and sp22 antibodies |
| 02/02/2006 | WO2006012525A2 Non-diabetogenic therapy using a 20kda placental growth hormone variant |
| 02/02/2006 | WO2006012419A2 Inhibition of nf-kb |
| 02/02/2006 | WO2006012402A1 Use of adiponectin to diagnose and treat malignancy |